美国 · SEC FORM 4
CYPHERPUNK TECHNOLOGIES INC.
CYPH · Nasdaq · CIK 0001509745 · Healthcare · Asset Management
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
7 同一窗口内观察到的 Form 4 交易行
3 sales · 4 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
—
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2021-09-24 · BeiGene, Ltd..
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 13,447,367
- 上期报告
- 9,853,398
- 日均成交量
- 22,275,542
- 回补天数
- ≤ 1.0
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
Form 4 申报证据
38 transaction lines in the latest 365-day window; 62 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-12 | Winklevoss Cameron Howard; Winklevoss Capital Fund, LLC; Winklevoss Capital Management, LLC; Winklevoss Treasury Investments, LLC; Winklevoss Tyler Howard | X (X) | Common Stock | 4,938,801 | USD 0.00 | USD 4,939 | SEC 申报 ↗ |
| 2026-10-12 | McEvoy William Patrick III | X (X) | Common Stock | 4,938,801 | USD 0.00 | USD 4,939 | SEC 申报 ↗ |
| 2026-09-25 | Oei Khing Djien | 卖出 (S) | Common Stock | 168,750 | USD 3.92 | USD 661,500 | SEC 申报 ↗ |
展开近期 Form 4 证据 (25 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-12 | Winklevoss Cameron Howard; Winklevoss Capital Fund, LLC; Winklevoss Capital Management, LLC; Winklevoss Treasury Investments, LLC; Winklevoss Tyler Howard | X (X) | Common Stock | 4,938,801 | USD 0.00 | USD 4,939 | SEC 申报 ↗ |
| 2026-10-12 | McEvoy William Patrick III | X (X) | Common Stock | 4,938,801 | USD 0.00 | USD 4,939 | SEC 申报 ↗ |
| 2026-09-25 | Oei Khing Djien | 卖出 (S) | Common Stock | 168,750 | USD 3.92 | USD 661,500 | SEC 申报 ↗ |
| 2026-09-23 | Martin Patricia A. | 卖出 (S) | Common Stock | 50,000 | USD 3.86 | USD 193,000 | SEC 申报 ↗ |
| 2026-08-26 | Dietz Thomas John | 卖出 (S) | Common Stock | 20,000 | USD 1.72 | USD 34,400 | SEC 申报 ↗ |
| 2026-08-17 | Winklevoss Cameron Howard; Winklevoss Capital Fund, LLC; Winklevoss Capital Management, LLC; Winklevoss Treasury Investments, LLC; Winklevoss Tyler Howard | X (X) | Common Stock | 16,570,852 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-17 | McEvoy William Patrick III | X (X) | Common Stock | 16,570,852 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-26 | Mirabelli Christopher | 卖出 (S) | Common Stock | 60,000 | USD 0.71 | USD 42,600 | SEC 申报 ↗ |
| 2026-03-13 | Schilsky Richard | 期权行权／转换 (M) | Common Stock | 168,750 | USD — | USD — | SEC 申报 ↗ |
| 2026-03-13 | Richard Christian M | 期权行权／转换 (M) | Common Stock | 168,750 | USD — | USD — | SEC 申报 ↗ |
| 2026-03-13 | Oei Khing Djien | 期权行权／转换 (M) | Common Stock | 168,750 | USD — | USD — | SEC 申报 ↗ |
| 2026-03-13 | Mirabelli Christopher | 期权行权／转换 (M) | Common Stock | 168,750 | USD — | USD — | SEC 申报 ↗ |
| 2026-03-13 | Mashiach Nissim | 期权行权／转换 (M) | Common Stock | 168,750 | USD — | USD — | SEC 申报 ↗ |
| 2026-03-13 | Martin Patricia A. | 期权行权／转换 (M) | Common Stock | 168,750 | USD — | USD — | SEC 申报 ↗ |
| 2026-03-13 | LOSCALZO JOSEPH | 期权行权／转换 (M) | Common Stock | 168,750 | USD — | USD — | SEC 申报 ↗ |
| 2026-03-13 | LI WILLIAM | 期权行权／转换 (M) | Common Stock | 168,750 | USD — | USD — | SEC 申报 ↗ |
| 2026-03-13 | Dietz Thomas John | 期权行权／转换 (M) | Common Stock | 104,500 | USD — | USD — | SEC 申报 ↗ |
| 2026-03-13 | CAVANAUGH JAMES H | 期权行权／转换 (M) | Common Stock | 168,750 | USD — | USD — | SEC 申报 ↗ |
| 2025-12-26 | Dietz Thomas John | 期权行权／转换 (M) | Common Stock | 83,000 | USD — | USD — | SEC 申报 ↗ |
| 2025-12-26 | Dietz Thomas John | 代扣税 (F) | Common Stock | 35,000 | USD 1.20 | USD 42,000 | SEC 申报 ↗ |
| 2025-12-23 | ONSI DOUGLAS E | J (J) | Common Stock | 2,848 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2025-12-23 | Mirabelli Christopher | J (J) | Common Stock | 2,848 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2025-11-17 | ONSI DOUGLAS E | 卖出 (S) | Common Stock | 676,319 | USD 3.14 | USD 2,123,642 | SEC 申报 ↗ |
| 2025-11-17 | Mirabelli Christopher | 卖出 (S) | Common Stock | 676,319 | USD 3.14 | USD 2,123,642 | SEC 申报 ↗ |
| 2025-11-17 | CAVANAUGH JAMES H | 卖出 (S) | Common Stock | 261,840 | USD 3.14 | USD 822,178 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | CYPH |
| CIK | 0001509745 |
| 行业 | Healthcare |
| 细分行业 | Asset Management Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 62 transaction lines from 2020-06-22 to 2026-10-12 2 P purchase lines · 9 S sale lines · 51 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.